CTLA4 and neoplasm: Immunotherapies such as checkpoint inhibitors that target cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or PD-1/PD-L1 and ionizing radiation require tumor-infiltrating lymphocytes and are less effective against immune ‘cold’ tumors15–20.